Identification of Diagnostic and Prognostic Subnetwork Biomarkers for Women with Breast Cancer Using Integrative Genomic and Network-Based Analysis
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252312779 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Olfat Al-Harazi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Oncology Department, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor, Protein Interaction Maps, Gene Regulatory Networks. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Faisal Specialist Hospital and Research Centre, research grant, King Salman Center for Disability Research.
Abstract (Originalsprache)
Breast cancer remains a major global health concern and a leading cause of cancer-related deaths among women. Early detection and effective treatment are essential in improving patient survival. Advances in omics technologies have provided deeper insights into the molecular mechanisms underlying breast cancer. This study aimed to identify subnetwork markers with diagnostic and prognostic potential by integrating genome-wide gene expression data with protein–protein interaction networks. We identified four significant subnetworks revealing potentially important hub genes, including VEGFA, KIF4A, ZWINT, PTPRU, IKBKE, STYK1, CENPO, and UBE2C. The diagnostic and prognostic potentials of these subnetworks were validated using independent datasets. Unsupervised principal component analysis demonstrated a clear separation of breast cancer patients from healthy controls across multiple datasets. A KNN classification model, based on these subnetworks, achieved an accuracy of 97%, sensitivity of 98%, specificity of 94%, and area under the curve (AUC) of 96%. Moreover, the prognostic significance of these subnetwork markers was validated using independent transcriptomic datasets comprising over 4000 patients. These findings suggest that subnetwork markers derived from integrated genomic network analyses can enhance our understanding of the molecular landscape of breast cancer, potentially leading to improved diagnostic, prognostic, and therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Oncology Department, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.
- Bioinformatics Laboratory, College of Computing, Mohammed VI Polytechnic University, Benguerir 43150, Morocco.
- Translational Genomics Department, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, Saudi Arabia.
ORCID-Profile: Achraf El Allali, Namik Kaya, Dilek Colak
Förderung
- King Faisal Specialist Hospital and Research Centre
- research grant
- King Salman Center for Disability Research
Zitieren
APA
Al-Harazi, O., El Allali, A., Kaya, N., & Colak, D. (2024). Identification of Diagnostic and Prognostic Subnetwork Biomarkers for Women with Breast Cancer Using Integrative Genomic and Network-Based Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312779
Vancouver
Al-Harazi O, El Allali A, Kaya N, Colak D. Identification of Diagnostic and Prognostic Subnetwork Biomarkers for Women with Breast Cancer Using Integrative Genomic and Network-Based Analysis. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312779
BibTeX
@article{AlHarazi2024,
author = {Al-Harazi, Olfat and El Allali, Achraf and Kaya, Namik and Colak, Dilek},
title = {Identification of Diagnostic and Prognostic Subnetwork Biomarkers for Women with Breast Cancer Using Integrative Genomic and Network-Based Analysis},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252312779}
}
EUVIMED